223 related articles for article (PubMed ID: 24452010)
1. A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening.
Hausmann R; Bahrenberg G; Kuhlmann D; Schumacher M; Braam U; Bieler D; Schlusche I; Schmalzing G
Neuropharmacology; 2014 Apr; 79():603-15. PubMed ID: 24452010
[TBL] [Abstract][Full Text] [Related]
2. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
[TBL] [Abstract][Full Text] [Related]
3. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
[TBL] [Abstract][Full Text] [Related]
4. 2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.
Neelands TR; Burgard EC; Uchic ME; McDonald HA; Niforatos W; Faltynek CR; Lynch KJ; Jarvis MF
Br J Pharmacol; 2003 Sep; 140(1):202-10. PubMed ID: 12967950
[TBL] [Abstract][Full Text] [Related]
5. [P2x3-receptor desensitization as an alternative mechanism of analgesia].
Petrenko NS; Kryshtal' OO
Fiziol Zh (1994); 2013; 59(2):104-10. PubMed ID: 23828978
[TBL] [Abstract][Full Text] [Related]
6. P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE₂ or dopamine.
de Oliveira Fusaro MC; Pelegrini-da-Silva A; Araldi D; Parada CA; Tambeli CH
Eur J Pharmacol; 2010 Dec; 649(1-3):177-82. PubMed ID: 20868656
[TBL] [Abstract][Full Text] [Related]
7. Highly conserved tyrosine 37 stabilizes desensitized states and restricts calcium permeability of ATP-gated P2X3 receptor.
Jindrichova M; Khafizov K; Skorinkin A; Fayuk D; Bart G; Zemkova H; Giniatullin R
J Neurochem; 2011 Nov; 119(4):676-85. PubMed ID: 21883226
[TBL] [Abstract][Full Text] [Related]
8. P2X purinergic receptor knockout mice reveal endogenous ATP modulation of both vasopressin and oxytocin release from the intact neurohypophysis.
Custer EE; Knott TK; Cuadra AE; Ortiz-Miranda S; Lemos JR
J Neuroendocrinol; 2012 Apr; 24(4):674-80. PubMed ID: 22340257
[TBL] [Abstract][Full Text] [Related]
9. Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+.
Li M; Silberberg SD; Swartz KJ
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3455-63. PubMed ID: 23959888
[TBL] [Abstract][Full Text] [Related]
10. High throughput functional assays for P2X receptors.
Namovic MT; Jarvis MF; Donnelly-Roberts D
Curr Protoc Pharmacol; 2012 Jun; Chapter 9():Unit 9.15.. PubMed ID: 22684723
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Ca2+ influx through recombinant P2X receptor in C6BU-1 cells.
Ueno S; Koizumi S; Inoue K
Br J Pharmacol; 1998 Aug; 124(7):1484-90. PubMed ID: 9723962
[TBL] [Abstract][Full Text] [Related]
12. AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.
Gever JR; Soto R; Henningsen RA; Martin RS; Hackos DH; Panicker S; Rubas W; Oglesby IB; Dillon MP; Milla ME; Burnstock G; Ford AP
Br J Pharmacol; 2010 Jul; 160(6):1387-98. PubMed ID: 20590629
[TBL] [Abstract][Full Text] [Related]
13. Role of the ectodomain serine 275 in shaping the binding pocket of the ATP-gated P2X3 receptor.
Petrenko N; Khafizov K; Tvrdonova V; Skorinkin A; Giniatullin R
Biochemistry; 2011 Oct; 50(39):8427-36. PubMed ID: 21879712
[TBL] [Abstract][Full Text] [Related]
14. P2X3 and P2X2/3 receptor antagonists.
Bölcskei H; Farkas B
Pharm Pat Anal; 2014 Jan; 3(1):53-64. PubMed ID: 24354979
[TBL] [Abstract][Full Text] [Related]
15. Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications.
Marucci G; Dal Ben D; Buccioni M; Martí Navia A; Spinaci A; Volpini R; Lambertucci C
Expert Opin Ther Pat; 2019 Dec; 29(12):943-963. PubMed ID: 31726893
[No Abstract] [Full Text] [Related]
16. P2X3 and P2X2/3 receptors activation induces articular hyperalgesia by an indirect sensitization of the primary afferent nociceptor in the rats' knee joint.
Teixeira JM; Parada CA; Tambeli CH
Eur J Pharmacol; 2020 Jul; 879():173054. PubMed ID: 32145326
[TBL] [Abstract][Full Text] [Related]
17. Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies.
Shcherbatko A; Foletti D; Poulsen K; Strop P; Zhu G; Hasa-Moreno A; Melton Witt J; Loo C; Krimm S; Pios A; Yu J; Brown C; Lee JK; Stroud R; Rajpal A; Shelton D
J Biol Chem; 2016 Jun; 291(23):12254-70. PubMed ID: 27129281
[TBL] [Abstract][Full Text] [Related]
18. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration.
Garceau D; Chauret N
Pulm Pharmacol Ther; 2019 Jun; 56():56-62. PubMed ID: 30902655
[TBL] [Abstract][Full Text] [Related]
19. Lipid raft association and cholesterol sensitivity of P2X1-4 receptors for ATP: chimeras and point mutants identify intracellular amino-terminal residues involved in lipid regulation of P2X1 receptors.
Allsopp RC; Lalo U; Evans RJ
J Biol Chem; 2010 Oct; 285(43):32770-32777. PubMed ID: 20699225
[TBL] [Abstract][Full Text] [Related]
20. Modulatory activity of extracellular H+ and Zn2+ on ATP-responses at rP2X1 and rP2X3 receptors.
Wildman SS; King BF; Burnstock G
Br J Pharmacol; 1999 Sep; 128(2):486-92. PubMed ID: 10510462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
